Passive

Vanguard Health Care Index Fund

Vanguard Health Care Index Fund (the “Fund”) seeks to track the performance of a benchmark index that measures the investment return of health care stocks.

$161.55

Key Metrics

TER 0.09% per year
Distribution policy Distributing
Fund size USD 18,988 M
Inception date February 5, 2004
Holdings 407
Fund currency USD
Fund domicile US
Provider Vanguard
For full official fund details, factsheets, and holdings, visit investor.vanguard.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Health Care Index Fund VHCIX
Fund Size
$19B
Dividend
1.4%
Fees
0.09%
Morningstar Total Stock Market Index Fund VTSAX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.04%
Morningstar Total Stock Market Index Fund VITSX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
Morningstar Total Stock Market Index Fund VSMPX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.02%
Morningstar Total Stock Market Index Fund VTI
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
View 1342 similar ETFs →

Historical Return

Last updated: Oct 15, 2026
1 Year +2.4% +1.4% Div
3 Years (avg.) +0.8% +1.4% Div
5 Years (avg.) +0.5% +1.4% Div

Risk & Analysis Metrics

Last updated: Oct 15, 2026

Volatility

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Max Drawdown

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Sharpe Ratio

N/A 1 Year
N/A 3 Years
N/A 5 Years
N/A 10 Years

Distributions

*by ETF Portfolio Weight Last updated: Oct 15, 2026

Profit Margin Distribution

< 0%
9%
1y 3y N/A N/A
0 - 5%
23%
1y 3y N/A N/A
5 - 10%
13%
1y 3y N/A N/A
10 - 15%
6%
1y 3y N/A N/A
15 - 20%
12%
1y 3y N/A N/A
20 - 30%
20%
1y 3y N/A N/A
30 - 40%
17%
1y 3y N/A N/A
> 40%
1%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
9%
1y 3y N/A N/A
0 - 10
0%
1y 3y N/A N/A
10 - 15
5%
1y 3y N/A N/A
15 - 20
7%
1y 3y N/A N/A
20 - 25
11%
1y 3y N/A N/A
25 - 35
24%
1y 3y N/A N/A
35 - 50
30%
1y 3y N/A N/A
> 50
15%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.2%
1y 3y N/A N/A
Small Cap
1.8%
1y 3y N/A N/A
Mid Cap
5.7%
1y 3y N/A N/A
Large Cap
40.4%
1y 3y N/A N/A
Mega Cap
51.9%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Oct 15, 2026
39.7% Top 5 Holdings
53.2% Top 10 Holdings
86.3% Top 50 Holdings
94.0% Top 100 Holdings
Top 5 Companies
LLY Lilly(Eli) & Co
14.4%
JNJ Johnson & Johnson
8.7%
ABBV Abbvie Inc
6.2%
UNH Unitedhealth Group Inc
5.6%
MRK Merck & Co Inc
4.8%

Latest News

2 days ago • youtube.com

Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast

Johnson & Johnson executive vice president and CFO Joe Wolk discusses the company's third-quarter earnings, raising its full-year guidance, a poten...
2 days ago • zacks.com

UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?

Healthcare giants UnitedHealth Group and Johnson & Johnson reported Q3 results on Tuesday, with both raising their full-year earnings outlooks but ...
2 days ago • youtube.com

J&J raises its forecast again. CFO Joe Wolk on what's driving it

Johnson & Johnson raised its full-year forecast again on October 13, 2026, and CFO Joe Wolk tells Yahoo Finance's Julie Hyman that pharmaceuticals ...

Sectors

Manufacturing 71.1%
Finance and Insurance 8.9%
Professional, Scientific, and Technical Services 5.2%
Health Care and Social Assistance 4.2%
Wholesale Trade 3.1%
Retail Trade 1.9%
Healthcare 1.4%
Information 0.1%
Construction 0.0%
Financial Services 0.0%
Health Technology 0.0%
Other 4.0%

Countries

United States 97.4%
Ireland 1.9%
United Kingdom 0.4%
Other 0.2%
Netherlands 0.1%
Switzerland 0.0%
Canada 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 375 investments below

375 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

Lilly(Eli) & Co

LLY - Manufacturing

Lilly(Eli) & Co

LLY - Manufacturing
Market Cap $1.45T
P/E Ratio 39.5
Dividends 0.6%
Total Investment $2.67B
Weight 14.04%

Loading details…

Johnson & Johnson

JNJ - Manufacturing

Johnson & Johnson

JNJ - Manufacturing
Market Cap $825.47B
P/E Ratio 30.2
Dividends 2.0%
Total Investment $1.61B
Weight 8.47%

Loading details…

Abbvie Inc

ABBV - Manufacturing

Abbvie Inc

ABBV - Manufacturing
Market Cap $787.43T
P/E Ratio 77.9
Dividends 2.5%
Total Investment $1.16B
Weight 6.09%

Loading details…

Unitedhealth Group Inc

UNH - Finance and Insurance

Unitedhealth Group Inc

UNH - Finance and Insurance
Market Cap $558.09T
P/E Ratio 24.4
Dividends 2.4%
Total Investment $1.03B
Weight 5.45%

Loading details…

Merck & Co Inc

MRK - Manufacturing

Merck & Co Inc

MRK - Manufacturing
Market Cap $366.59B
P/E Ratio 115.6
Dividends 2.3%
Total Investment $885M
Weight 4.66%

Loading details…

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services
Market Cap $322.95B
P/E Ratio 35.3
Dividends 0.3%
Total Investment $555.74M
Weight 2.93%

Loading details…

AMGEN Inc.

AMGN - Manufacturing

AMGEN Inc.

AMGN - Manufacturing
Market Cap $223.91B
P/E Ratio 25.6
Dividends 2.4%
Total Investment $544.66M
Weight 2.87%

Loading details…

Gilead Sciences, Inc.

GILD - Manufacturing

Gilead Sciences, Inc.

GILD - Manufacturing
Market Cap $187.44B
P/E Ratio -58.1
Dividends 2.1%
Total Investment $500.92M
Weight 2.64%

Loading details…

Intuitive Surgical Inc

ISRG - Manufacturing

Intuitive Surgical Inc

ISRG - Manufacturing
Market Cap $151.64B
P/E Ratio 47.9
Dividends 0.0%
Total Investment $452.1M
Weight 2.38%

Loading details…

Pfizer Inc.

PFE - Manufacturing

Pfizer Inc.

PFE - Manufacturing
Market Cap $259.61T
P/E Ratio 37.4
Dividends 6.1%
Total Investment $447.04M
Weight 2.35%

Loading details…

Abbott Laboratories

ABT - Manufacturing

Abbott Laboratories

ABT - Manufacturing
Market Cap $172.35B
P/E Ratio 32.0
Dividends 2.5%
Total Investment $447.02M
Weight 2.35%

Loading details…

Bristol-Myers Squibb Co.

BMY - Manufacturing

Bristol-Myers Squibb Co.

BMY - Manufacturing
Market Cap $814.59B
P/E Ratio 13.0
Dividends 4.3%
Total Investment $349.61M
Weight 1.84%

Loading details…

Danaher Corp.

DHR - Manufacturing

Danaher Corp.

DHR - Manufacturing
Market Cap $916.76B
P/E Ratio 38.9
Dividends 0.7%
Total Investment $348.74M
Weight 1.84%

Loading details…

CVS Health Corp

CVS - Retail Trade

CVS Health Corp

CVS - Retail Trade
Market Cap $110.74B
P/E Ratio 22.5
Dividends 3.1%
Total Investment $346.91M
Weight 1.83%

Loading details…

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing
Market Cap $130.38B
P/E Ratio 29.5
Dividends 0.0%
Total Investment $341.05M
Weight 1.80%

Loading details…

Stryker Corp.

SYK - Manufacturing

Stryker Corp.

SYK - Manufacturing
Market Cap $106.32B
P/E Ratio 28.5
Dividends 1.3%
Total Investment $315.33M
Weight 1.66%

Loading details…

Mckesson Corporation

MCK - Wholesale Trade

Mckesson Corporation

MCK - Wholesale Trade
Market Cap $116.19B
P/E Ratio 25.0
Dividends 0.4%
Total Investment $275.2M
Weight 1.45%

Loading details…

Anthem Inc

ANTM - Finance and Insurance

Anthem Inc

ANTM - Finance and Insurance
Market Cap $114.59B
P/E Ratio 18.3
Dividends 1.7%
Total Investment $256.81M
Weight 1.35%

Loading details…

Cigna Group (The)

CI - Finance and Insurance

Cigna Group (The)

CI - Finance and Insurance
Market Cap $74.63B
P/E Ratio 11.6
Dividends 2.2%
Total Investment $222.56M
Weight 1.17%

Loading details…

Boston Scientific Corp.

BSX - Healthcare

Boston Scientific Corp.

BSX - Healthcare
Market Cap $175.45B
P/E Ratio 17.2
Dividends 0.0%
Total Investment $215.12M
Weight 1.13%

Loading details…